| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Variables | P | HR (95%CI) | P | HR (95%CI) |
Bisphosphonate medication | ||||
 No |  | Ref |  |  |
 Yes | 0.602 | 1.14(0.69—1.89) |  |  |
Gender | ||||
 Female |  | Ref |  |  |
 Male | 0.545 | 1.21(0.65—2.28) |  |  |
Laterality | ||||
 Unilateral MD and contralateral THA |  | Ref |  |  |
 Unilateral | 0.302 | 1.33(0.77—2.31) |  |  |
 Bilateral | 0.252 | 0.74(0.45—1.24) |  |  |
Etiology | ||||
 Idiopathic |  | Ref |  |  |
 Corticosteroid | 0.151 | 1.47(0.87—2.5) |  |  |
 Alcohol-related | 0.187 | 0.57(0.24—1.32) |  |  |
ARCO classification | ||||
 ARCO I |  | Ref |  | Ref |
 ARCO II | 0.157 | 0.7(0.42—1.15) | 0.157 | 0.69 (0.42—1.14) |
 ARCO IIIA | 0.005 | 2.12(1.25—3.59) | 0.037 | 2.12 (1.25—3.58) |
Bone marrow edema | ||||
 No |  | Ref |  | Ref |
 Yes | 0.011 | 2.13(1.19—3.81) | 0.010 | 2.13 (1.19—3.81) |
Location | ||||
 Type B |  | Ref |  |  |
 Type C1 | 0.124 | 0.64(0.36—1.13) |  |  |
 Type C2 | 0.051 | 1.73(1—2.98) |  |  |
Age | ||||
 < 42.00 |  | Ref |  |  |
 ≥ 42.00 | 0.174 | 1.42(0.86—2.37) |  |  |
BMI | ||||
 < 23.71 |  | Ref |  |  |
 ≥ 23.71 | 0.238 | 1.35(0.82—2.22) |  |  |
Symptom duration | ||||
 < 2.00 |  | Ref |  |  |
 ≥ 2.00 | 0.526 | 0.85(0.52—1.4) |  |  |
Combined necrotic angle | ||||
 < 210.50 |  | Ref |  | Ref |
≥ 210.50 | 0.001 | 2.42(1.44—4.07) |  < 0.001 | 2.41 (1.43—4.07) |
Necrosis degree index | ||||
 < 109.67 |  | Ref |  |  |
 ≥ 109.67 | 0.001 | 2.35(1.39—3.95) |  |  |